Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide add-on to tiotropium in COPD
NCT00860938Phase 4Completed
- Sponsor
- Kantonsspital Baselland
- Start
- Apr 2007
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Kantonsspital Baselland. Primary endpoint: Forced Expiratory Volume in 1 Second at 12 weeks. Started Apr 2007; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00860938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860938.